PHARMAMAR HA OPTADO POR LA RETIRADA DE LA SOLICITUD DE AUTORIZACIÓN DE COMERCIALIZACIÓN DE APLIDIN ( PLITIDEPSIN ) ... WITHDRAWAL OF APPLICATIÓN FOR THE MARKETING AUTHORISATION OF APLIDIN ( PLITIDEPSIN ) JULY 23 , 2025 .
29 abril 2020
PharmaMar Signs an Agreement with Immedica Pharma To Market Lurbinectedin in Eastern Europe, the UK, Ireland, the Nordic Countries and Some Middle Eastern Countries.
